APOB and metabolic syndrome: Evidence shows that arachidonic acid is associated with dyslipidemia and cholesterol-associated lipoprotein metabolism and that arachidonic acid increased plasma concentrations of TC and ApoB, as well as elevated ApoB protein expression and decreased protein expression of ABCG5/8 in mice (Li et al., 2022).